Menu
Back toAgenda
Marketing Pharmaceuticals 2016
Agenda
Day 1
Day 2
- — Continental Breakfast, Exhibits, and Networking
- — Registration
- — Welcome Remarks
- — Session 1: Ad-Promo Litigation: Amarin and Beyond
- — Refreshment Break, Exhibits, and Networking
- — Session 2: Engaging Payers, Nontraditional, and Emerging Customer Markets
- — Luncheon, Exhibits, and Networking
- — Session 3A: Safety Labeling Changes - Real-World Execution Into Packaging, Advertising and Promotion, and Beyond
- — Session 3B: Global Promotion Review Process and Standards
- — Session 3C: Mock Review: A Regulatory Perspective
- — Refreshment Break, Exhibits, and Networking
- — Session 4A: Safety Labeling Changes - Real-World Execution Into Packaging, Advertising and Promotion, and Beyond
- — Session 4B: Global Promotion Review Process and Standards
- — Session 4C: Mock Review: A Regulatory Perspective
- — Poster Session and Networking Reception
Day 3
- — Continental Breakfast, Exhibits, and Networking
- — Registration
- — Welcome to Day Two
- — Session 5: FDA Update: Recent Enforcement Actions and Guidances
- — Refreshment Break, Exhibits, and Networking
- — Session 6: Using New and Emerging Technologies Compliantly
- — Luncheon and Exhibits
- — Luncheon, Round Table Discussions, and Exhibits
- — Session 7A: Scientific Exchange and the Responsible Sharing of Truthful and Non Misleading Information About Medicines with HCPs
- — Session 7B: Advocacy Groups: When and How Should They be Engaged?
- — Session 7C: Review Standards for Ad Boards and Consultant Meetings
- — Refreshment Break, Exhibits, and Networking
- — Session 8: Compliance Update Panel
- — Closing Session: Question and Answer with FDA
Contact us
Registration Questions?


